Key result
Targeted epicardial fat pad botulinum toxin injection reduces three-year AF incidence following CABG.
Why the study?
Growing evidence indicates that cardiac fibrosis and neuronal remodeling are intertwined processes within the intrinsic cardiac nervous system.
Recognizing neurofibrosis as a companion process to myocardial fibrosis reframes therapeutic strategies toward preserving both neural and myocardial integrity.
No takes yet. Share an insight, caveat, or question.
May support neuromodulation in CABG AF prevention; leaves open neurofibrosis-targeted mechanisms.
The heart’s performance relies on its contractile and rhythmic properties, which are modulated not only by extrinsic autonomic inputs but also by the intrinsic cardiac nervous system (ICNS), a distributed network of intracardiac ganglia and neurons that integrates local sensory, autonomic, and inflammatory signals. Growing evidence indicates that cardiac fibrosis and neuronal remodeling are intertwined processes within this network. This review synthesizes current knowledge on molecular, structural, and functional remodeling of the ICNS to drive neurofibrosis, autonomic imbalance, and arrhythmogenesis. We outline ICNS anatomy and neurochemical diversity, then summarize core fibrotic mechanisms, fibroblast activation, extracellular matrix dynamics, and inflammatory signaling, and map these onto intracardiac ganglia. Across diabetes, myocardial infarction, heart failure, and neuroinflammatory states, shared pathways (e.g., IL-6/STAT3, TGF-β/SMAD, PI3K/AKT, MAPK/ERK, oxidative stress) suppress neuronal excitability, promote neuron–glia–fibroblast coupling, and culminate in neurofibrotic remodeling. We integrate functional data linking these changes to autonomic dysregulation and arrhythmia vulnerability. Future priorities involve constructing detailed human ICNS atlases and applying single-cell and spatial multi-omics to better characterize intracardiac neurons, their circuitry, and their interactions with fibroblasts and immune cells. These insights will be essential to inform targeted neuromodulation and anti-fibrotic interventions. The ICNS is a dynamic regulatory hub whose cells and circuits participate directly in cardiac fibrosis and electrical instability. Recognizing neurofibrosis as a companion process to myocardial fibrosis reframes therapeutic strategy toward preserving both neural and myocardial integrity.
Gemayel et al. (2026) conducted a review in Patients with cardiac diseases involving intrinsic cardiac nervous system remodeling such as type 2 diabetes mellitus, myocardial infarction, and heart failure. Targeted neuromodulation with botulinum toxin injection into epicardial fat pads reduced atrial fibrillation incidence over three years in patients undergoing coronary artery bypass grafting.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: